Audubon, PA, United States of America

M Amparo Lago


Average Co-Inventor Count = 4.9

ph-index = 3

Forward Citations = 13(Granted Patents)


Company Filing History:


Years Active: 1998-1999

Loading Chart...
3 patents (USPTO):Explore Patents

Title: M Amparo Lago: Innovator in Cardiovascular and Renal Treatments

Introduction

M Amparo Lago is a distinguished inventor based in Audubon, PA (US). She has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that target cardiovascular and renal diseases. With a total of three patents to her name, her work has the potential to impact many lives.

Latest Patents

M Amparo Lago's latest patents include innovative compounds such as benzimidazoles and imidazoles linked to a fibrinogen receptor antagonist. Additionally, she has developed endothelin receptor antagonists and dihydroisoindole compounds, which are disclosed as being useful in treating various cardiovascular and renal conditions. These advancements highlight her commitment to addressing critical health issues.

Career Highlights

Throughout her career, M Amparo Lago has been associated with SmithKline Beecham Corporation, where she has contributed her expertise in pharmaceutical research and development. Her work has been instrumental in advancing the understanding and treatment of diseases that affect millions.

Collaborations

M Amparo Lago has collaborated with notable colleagues, including John Duncan Elliott and Robert Gene Franz. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.

Conclusion

M Amparo Lago's contributions to the field of pharmaceuticals demonstrate her dedication to improving health outcomes through innovative research. Her patents reflect a commitment to developing effective treatments for cardiovascular and renal diseases, showcasing her as a leading figure in her field.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…